• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[高血容量对常染色体显性遗传性多囊肾病患者电解质水平及容量调节激素水平的影响]

[The effect of hypervolemia on electrolyte level and and level of volume regulating hormones in patients with autosomal dominant polycystic kidney disease].

作者信息

Michalski A, Grzeszczak W

机构信息

Katedra i Klinika Chorób Wewnetrznych i Zawodowych Slaskiej Akademii Medycznej w Zabrzu.

出版信息

Pol Arch Med Wewn. 1996 Oct;96(4):329-43.

PMID:9082344
Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is one of the most frequent autosomal dominant diseases. Apart from kidneys it also includes alimentary system, nervous system, cardiovascular system. ADPKD is associated with endocrinal disorders of the hormones regulating volume, arterial blood pressure and water and electrolyte balance such as: ARO, AVP, Aldo. 24 patients with ADPKD (12 with normal renal function-gr. III, 12 with advanced renal insufficiency-gr. IV) and 15 healthy subjects to compare with-gr. I and 16 patients with advanced renal insufficiency of other origin than ADPKD-gr. II were examined. In all groups the levels of Aldo, AVP and ARO in blood and Na+, K+ and creatinine concentrations in blood serum were examined Also an excretion of Na, K, creatinine with urine and clearances: CNa, CK, CKrea and filtration fractions: FENa and FEK were determined. Arterial blood pressure was measured in all groups. The above described parameters were studied in standard conditions in patients in supine position and fasting-survey I; directly after intravenous infusion of 1000 ml 0.16 M NaCl at 16.7 ml/min for 1 h-survey II and two hours after intravenous infusion-survey III. Isotonic intravenous infusion of natrium chloride increased central blood volume in the examined patients (induced hypervolemia). The received results were compared among groups in standard conditions (before infusion) as well as reaction of all groups to increased central volemia was compared. On the basis of the received results it was observed that the patients with ADPKD with normal renal function (gr III) show a significant increase of ARO, AVP, arterial blood pressure what differs them from healthy individuals (gr. I). The increased values of the above mentioned parameters were typical for the patients with chronic renal insufficiency regardless to a cause of the failure (gr. II). Consequently, patients with ADPKD showed some hormonal disorders typical for patients with advanced renal insufficiency despite fairly big difference in creatinine level and renal function condition among groups. Comparing the groups with advanced renal insufficiency (gr. II and gr. IV) it was shown that despite the same creatinine and electrolytes level in blood serum they exhibited different renine activity of serum and arterial blood pressure. These parameters were higher in the group with ADPKD. After volume expansion by 1000 ml 0.16 M NaCl infusion no significant differences between renal response to induced hypervolemia in patients with ADPKD and control groups were observed. The received results show that the patients with ADPKD exhibit disorders in hormonal regulation, water and electrolyte balance and in value of arterial blood pressure regardless to a degree of renal function. Thus genetic disease alone predisposes to the above mentioned disorder. Nevertheless, patients with ADPKD show normal mechanisms of renal volemic regulation in volume expansion conditions that can be compared to control groups. It also means that renal response to induced hypervolemia is similar in all the examined groups and is independent of renal function degree.

摘要

常染色体显性多囊肾病(ADPKD)是最常见的常染色体显性疾病之一。除了肾脏外,它还累及消化系统、神经系统和心血管系统。ADPKD与调节血容量、动脉血压以及水和电解质平衡的激素的内分泌紊乱有关,如:促红细胞生成素(ARO)、抗利尿激素(AVP)、醛固酮(Aldo)。研究了24例ADPKD患者(12例肾功能正常——III级,12例晚期肾功能不全——IV级)以及15名作为对照的健康受试者——I级,还有16例非ADPKD所致晚期肾功能不全的患者——II级。检测了所有组血液中醛固酮、抗利尿激素和促红细胞生成素的水平以及血清中钠、钾和肌酐的浓度。还测定了尿中钠、钾、肌酐的排泄量以及清除率:钠清除率(CNa)、钾清除率(CK)、肌酐清除率(CKrea)和滤过分数:滤过钠分数(FENa)和滤过钾分数(FEK)。测量了所有组的动脉血压。在标准条件下对患者进行上述参数的研究,患者仰卧位且禁食——调查I;以16.7 ml/分钟的速度静脉输注1000 ml 0.16 M氯化钠1小时后——调查II;静脉输注两小时后——调查III。等渗氯化钠静脉输注增加了受试患者的中心血容量(诱发高血容量)。将标准条件下(输注前)各组的所得结果进行比较,同时比较所有组对中心血容量增加的反应。根据所得结果观察到,肾功能正常的ADPKD患者(III级)促红细胞生成素、抗利尿激素、动脉血压显著升高,这使其有别于健康个体(I级)。无论肾衰竭的病因如何(II级),上述参数升高的值对于慢性肾功能不全患者来说是典型的。因此,ADPKD患者尽管各组间肌酐水平和肾功能状况差异很大,但仍表现出一些晚期肾功能不全患者典型的激素紊乱。比较晚期肾功能不全组(II级和IV级)发现,尽管血清肌酐和电解质水平相同,但它们的血清肾素活性和动脉血压不同。ADPKD组的这些参数更高。在输注1000 ml 0.16 M氯化钠使血容量增加后,未观察到ADPKD患者与对照组对诱发高血容量的肾脏反应有显著差异。所得结果表明,无论肾功能程度如何,ADPKD患者在激素调节、水和电解质平衡以及动脉血压值方面均存在紊乱。因此,仅这种遗传性疾病就易导致上述紊乱。然而,ADPKD患者在血容量增加的情况下表现出正常的肾脏血容量调节机制,这可与对照组相比较。这也意味着在所有受试组中,对诱发高血容量的肾脏反应相似,且与肾功能程度无关。

相似文献

1
[The effect of hypervolemia on electrolyte level and and level of volume regulating hormones in patients with autosomal dominant polycystic kidney disease].[高血容量对常染色体显性遗传性多囊肾病患者电解质水平及容量调节激素水平的影响]
Pol Arch Med Wewn. 1996 Oct;96(4):329-43.
2
Urine concentration ability is reduced to the same degree in adult dominant polycystic kidney disease compared with other chronic kidney diseases in the same CKD-stage and lower THAN in healthy control subjects - a CASE control study.在相同 CKD 分期的成人显性多囊肾病与其他慢性肾脏病相比,尿液浓缩能力降低的程度相同,且低于健康对照组——一项病例对照研究。
BMC Nephrol. 2020 Aug 31;21(1):379. doi: 10.1186/s12882-020-02043-w.
3
Urinary excretion of AQP2 and ENaC in autosomal dominant polycystic kidney disease during basal conditions and after a hypertonic saline infusion.常染色体显性多囊肾病患者在基础状态和高渗盐水输注后的尿 AQP2 和 ENaC 排泄。
Am J Physiol Renal Physiol. 2012 Apr 15;302(8):F917-27. doi: 10.1152/ajprenal.00616.2011. Epub 2012 Jan 18.
4
Differences in hormonal and renal vascular responses between normotensive patients with autosomal dominant polycystic kidney disease and unaffected family members.常染色体显性多囊肾病高血压患者与未患病家庭成员之间激素和肾血管反应的差异。
Kidney Int. 1994 Oct;46(4):1118-23. doi: 10.1038/ki.1994.374.
5
Renal response to prostaglandin E1 infusion in polycystic kidney disease versus non-polycystic renal disease.多囊肾病与非多囊肾病中肾脏对前列腺素E1输注的反应。
Clin Nephrol. 1995 Oct;44(4):225-30.
6
Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment.血管加压素、 copeptin 和肾功能正常的常染色体显性多囊肾病患者的肾浓缩能力。
Clin J Am Soc Nephrol. 2012 Jun;7(6):906-13. doi: 10.2215/CJN.11311111. Epub 2012 Apr 19.
7
[Blood pressure, functional and morphological study of kidneys in children with autosomal dominant polycystic kidney disease].[常染色体显性多囊肾病患儿的血压、肾脏功能及形态学研究]
Cas Lek Cesk. 1999 Mar 15;138(6):178-84.
8
Borderline hypertensive autosomal dominant polycystic kidney disease patients have enhanced production of renal dopamine. Normalization of renal haemodynamics by DOPA infusion.临界高血压常染色体显性多囊肾病患者肾多巴胺生成增加。通过多巴输注使肾血流动力学正常化。
Nephrol Dial Transplant. 1995;10(8):1332-41.
9
Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.常染色体显性多囊肾病(ADPKD)早期的肾脏结构:多囊肾病放射影像学研究联盟(CRISP)队列
Kidney Int. 2003 Sep;64(3):1035-45. doi: 10.1046/j.1523-1755.2003.00185.x.
10
Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients.在常染色体显性遗传性多囊肾病患者中,尿血管紧张素原/肌酐(AGT/Cr)比值升高可能与肾功能降低有关。
BMC Nephrol. 2015 Jun 20;16:86. doi: 10.1186/s12882-015-0075-8.

引用本文的文献

1
Water Drinking Practices in ADPKD Patients: A Questionnaire Based Study.常染色体显性多囊肾病患者的饮水习惯:一项基于问卷调查的研究
Indian J Nephrol. 2021 Nov-Dec;31(6):507-510. doi: 10.4103/ijn.IJN_379_19. Epub 2021 Apr 2.
2
Vasopressin and disruption of calcium signalling in polycystic kidney disease.血管加压素与多囊肾病中钙信号传导的破坏
Nat Rev Nephrol. 2015 Aug;11(8):451-64. doi: 10.1038/nrneph.2015.39. Epub 2015 Apr 14.
3
Renal cyst growth is the main determinant for hypertension and concentrating deficit in Pkd1-deficient mice.
肾囊肿生长是多囊蛋白1缺陷小鼠高血压和浓缩功能缺陷的主要决定因素。
Kidney Int. 2014 May;85(5):1137-50. doi: 10.1038/ki.2013.501. Epub 2014 Jan 15.
4
Calmodulin-sensitive adenylyl cyclases mediate AVP-dependent cAMP production and Cl- secretion by human autosomal dominant polycystic kidney cells.钙调蛋白敏感的腺苷酸环化酶介导人常染色体显性遗传性多囊肾病细胞的 AVP 依赖性 cAMP 产生和 Cl-分泌。
Am J Physiol Renal Physiol. 2012 Nov 15;303(10):F1412-24. doi: 10.1152/ajprenal.00692.2011. Epub 2012 Sep 5.
5
Tolvaptan inhibits ERK-dependent cell proliferation, Cl⁻ secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin.托伐普坦抑制血管加压素刺激的人 ADPKD 细胞的 ERK 依赖性细胞增殖、Cl⁻分泌和体外囊泡生长。
Am J Physiol Renal Physiol. 2011 Nov;301(5):F1005-13. doi: 10.1152/ajprenal.00243.2011. Epub 2011 Aug 3.
6
Polycystic kidney disease: inheritance, pathophysiology, prognosis, and treatment.多囊肾病:遗传、病理生理学、预后及治疗
Int J Nephrol Renovasc Dis. 2010;3:69-83. doi: 10.2147/ijnrd.s6939. Epub 2010 Jun 24.
7
Cyclic AMP-mediated cyst expansion.环磷酸腺苷介导的囊肿扩张。
Biochim Biophys Acta. 2011 Oct;1812(10):1291-300. doi: 10.1016/j.bbadis.2010.11.005. Epub 2010 Nov 28.
8
Copeptin, a surrogate marker of vasopressin, is associated with disease severity in autosomal dominant polycystic kidney disease. copeptin,一种加压素的替代标志物,与常染色体显性遗传性多囊肾病的疾病严重程度相关。
Clin J Am Soc Nephrol. 2011 Feb;6(2):361-8. doi: 10.2215/CJN.04560510. Epub 2010 Oct 7.
9
Vasopressin antagonists in polycystic kidney disease.多囊肾病中的血管加压素拮抗剂
Semin Nephrol. 2008 May;28(3):306-17. doi: 10.1016/j.semnephrol.2008.03.003.
10
Potential pharmacological interventions in polycystic kidney disease.多囊肾病的潜在药物干预措施。
Drugs. 2007;67(17):2495-510. doi: 10.2165/00003495-200767170-00004.